The markets traded mixed during the midday with the Dow slipping 22 points to 11,733 as rising food and energy costs lifted wholesale prices in December. Nasdaq added a point to 2738.
On the upside
Biodel (Nasdaq: BIOD) presented a corporate update including developments of its rapid acting insulin product Linjeta at the J. P. Morgan Healthcare Conference this morning.
Fourth quarter revenue for SAP (NYSE: SAP) surged to surpass analyst expectations.
First quarter earnings and revenue surged for EXFO (Nasdaq: EXFO) to beat estimates.
On the downside
An analyst said that Tenaris (NYSE: TS) trimmed its fourth quarter outlook.
BioCryst Pharmaceuticals (Nasdaq: BCRX) requested changes to a late stage clinical trial of its influenza treatment peramivir.
Infosys Technologies (Nasdaq: INFY) reported higher third quarter earnings but warned of slowing growth as the economic recovery slows.
